A New Year, but the Same Old Stock Market
The new year was to have brought a new beginning for China's stock market. Instead, investors who were set to welcome the return of IPO action after a suspension of 14 months were disappointed by news on January 10 that Jiangsu Aosaikang Pharmaceutical Co. Ltd. was putting its anticipated initial public offering on hold.
The abrupt postponement has sparked questions about the regulator's reform agenda. Clearly, at a time when it is trying to clarify its own role vis-à-vis the market, the regulator has yet to master the art of timing. Xiao Gang, chairman of the China Securities Regulatory Commission, said at a work conference this month that reform will see a complete overhaul of the regulator's scope of oversight of the capital market. Its recent actions must be seen in light of this pledge.
- China's Workers Earned More in 2014, but Percent Raises Shrank
- Big Blast
- China Telecom Confirms Severed Cables Caused Alipay Disruption
- The 'Liquidity Trap' with Chinese Characteristics
- Graphics: Expansion Expectations
- China Uses Drones to Monitor Pollution Problem from Above
- Experts Question Alipay's Backup Plans after Long Glitch
- Parents in Capital Angry at Recruiting Changes for Top Primary Schools
- A Prince's Legacy
- Emissions from Nation's Incineration Plants 'Surpass Standards'
- Sign up to receive our free daily newsletter
- Phone Maker Transsion Catches the African Beat
- Solar Panel Maker Suffering HK Share Sell-Off 'Failed to Repay Loans'
- The Big VIE Question
- South China Sea Issue Is Litmus Test for Sino-U.S. Relationship
- China Unleashes Bonds to Tackle Local Debt
- Gov't Announces Plan to Upgrade Factories over Next Decade
- Rescue in the Works for Indebted Sinosteel
- Residents of Beijing Community Renew Protest against Waste Incineration Plant
- Banks Face Obstacles to Using Biometric Data for ID Purposes
- Party's 'United Front' Meeting Said to Be Aimed at Earning Reform Support